SCHEMBL985350

SCHEMBL985350

CC(=O)N[C@H]1CC[C@H](NC(=O)c2c[nH]c3c(-c4ccc(F)cc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 5/20 0.41
CASP3 P42574 1/20 0.41
CASP7 P55210 1/20 0.41
BTK Q06187 1/20 0.40
CDK1 P06493 4/20 0.39
CDK2 P24941 4/20 0.39
CDK3 Q00526 3/20 0.38
CDK5 Q00535 3/20 0.38
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
CCNT1 O60563 2/20 0.38
CCNB1 P14635 2/20 0.38
CCNE1 P24864 2/20 0.38
CCNA1 P78396 2/20 0.38
CDK5R1 Q15078 2/20 0.38
KDM5A P29375 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
HTR2A P28223 2/20 0.37
DRD3 P35462 2/20 0.37
CYP4F2 P78329 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL986391 1.00 CDK9 (0.41) CDK9CASP3CASP7BTKCDK1
SCHEMBL984446 0.94 BTK (0.40) CDK9CASP3CASP7BTKCDK1
SCHEMBL981859 0.92 SMYD3 (0.41) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL984182 0.92 SMYD3 (0.41) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL984894 0.91 GRIN1 (0.36) CDK9CCNT1KDM5AKDM4CCRHR1
SCHEMBL985885 0.91 GRIN1 (0.36) CDK9CCNT1KDM5AKDM4CCRHR1
SCHEMBL984646 0.91 ACKR3 (0.41) KDM5AKDM4CALDH1A1KMT2ASCN8A
SCHEMBL982008 0.91 BTK (0.40) BTKCYP4F2CYP4A11KMT2AADORA2A
SCHEMBL985602 0.90 CSNK2A2 (0.38) KDM5AKDM4CCRHR1ALDH1A1KMT2A
SCHEMBL984058 0.90 CSNK2A2 (0.38) KDM5AKDM4CCRHR1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A CDK9 639/4885CASP3 1097/4885CASP7 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.